Sign in

CIK 0001427570

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Vyome Holdings, Inc

Sign in to watch
Ticker
HIND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-429-6680
Business address
1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
Former names
ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4/A Derivatives Options or other derivatives
  4. 4 Grant or award Vice President of Sales acquired 5,494 shares (grant or award)
  5. 4 Grant or award Director acquired 27,472 shares (grant or award)
  6. 4 Grant or award Director acquired 27,472 shares (grant or award)
  7. 4 Grant or award Pres & Chief Operating Officer acquired 54,945 shares (grant or award)
  8. 4 Grant or award Chief Technology Officer acquired 107,142 shares (grant or award)
  9. 4 Grant or award VP of Finance acquired 32,967 shares (grant or award)
  10. 4 Grant or award VP of Quality Assurance acquired 2,747 shares (grant or award)
  11. 4 Grant or award VP of Reg. and Clin. Affairs acquired 10,989 shares (grant or award)
  12. 4 Grant or award VP Research and Development acquired 13,736 shares (grant or award)
  13. 4 Grant or award CEO acquired 109,890 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 27,472 shares (grant or award)
  15. 4 Grant or award Director acquired 27,472 shares (grant or award)
  16. 4 Grant or award Director acquired 5,494 shares (grant or award)
  17. 4 Grant or award VP of Operations acquired 13,736 shares (grant or award)
  18. 4 Open-market buy Director bought 54,945 shares at $1.82 ($100,000)
  19. 4 Open-market buy 10% owner bought 1,648,359 shares at $1.82 ($3,000,013)
  20. 4 Open-market buy 10% owner bought 1,098,901 shares at $1.82 ($2,000,000)

Page 7 of 13 · 243 filings